Results 161 to 170 of about 17,612,218 (346)

Orthodontics: treatment need and treatment outcome

, 1997
Promotor : Kuijpers-Jagtman, A.M. Co-promotor : Hof, M.A.
openaire   +2 more sources

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Molecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte, Osheen Sharma, Laura Leuenberger, Emelie Wallin, Josefin Fernebro, Päivi Östling, Rebecka Bergström, Johan Lindberg, Ulrika Joneborg, Olli Kallioniemi, Brinton Seashore‐Ludlow   +10 more
wiley   +1 more source

Delay in diagnosis of retinoblastoma: risk factors and treatment outcome [PDF]

, 1999
Anthony Goddard, J E Kingston, John L. Hungerford   +2 more
openalex   +1 more source

Evaluating treatment outcomes [PDF]

Psychiatric Bulletin, 1990
Jacqueline Bailey, Phil Anthony, David Thompson   +2 more
openaire   +2 more sources

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

Exploring Mycobacterium riyadhense: Epidemiology, Clinical Presentation, and Treatment Outcome. [PDF]

Open Forum Infect Dis
Alsaeed M, Alanazi K, Alhamdan A, Faqihi M, Alibrahim A, Alshehri S, Shosha D, Alraddadi M, Alsaeed M, Alabdullah M, Ahmad S.   +10 more
europepmc   +1 more source

The pattern of changes in ovarian stromal and uterine artery blood flow velocities during in vitro fertilization treatment and its relationship with outcome of the cycle [PDF]

, 1999
Lawrence Engmann, P. Sladkevicius, Richa Agrawal, Jinan Bekir, S. Campbell, Seang Lin Tan   +5 more
openalex   +1 more source

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

Lancet Neurology, 2013
M. Titulaer, Lindsey Mccracken, I. Gabilondo, T. Armangué, C. Glaser, T. Iizuka, L. Honig, S. Benseler, I. Kawachi, E. Martínez-Hernandez, E. Aguilar, N. Gresa-arribas, Nicole Ryan-Florance, A. Torrents, A. Saiz, M. Rosenfeld, R. Balice-Gordon, F. Graus, J. Dalmau   +18 more
semanticscholar   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Measuring Satisfaction with Minimally Invasive Aesthetic Treatments with the SKIN-Q Treatment Outcome Scale. [PDF]

Aesthet Surg J
Klassen AF, Rae C, Gallo L, Cano S, Kaur M, Dayan S, Armstrong K, Poulsen L, Tsangaris E, Santosa KB, Pusic AL.   +10 more
europepmc   +1 more source